The released siNF-κB reduced the level of oxidative stress in AD neurons by downregulating NF-κB.771,772 The polymeric, small molecule, and nucleic acid drugs synergistically treated AD via Aβ aggregates, phosphorylated tau protein, and ROS, respectively. Here, MAPT is linked to Alzheimer disease.